What are mostOvervalued drug manufacturers - general stocks?
They are Drug Manufacturers - General names trading above modeled intrinsic value—shown here as downside % versus price. Models vary; use this as a screen, not advice.
Search companies or stocks...
Top MostOvervalued Drug Manufacturers - General industry Stocks 2026
GSK (GSK) is the most overvalued stock in the Drug Manufacturers - General industry with an estimated 70.6% downside, followed by Eli Lilly and Company (LLY) at 42.3%, AbbVie (ABBV) at 38.1%, and Gilead Sciences, (GILD) at 32.5%.
Updated todayBased on intrinsic value modelsIndustry: Drug Manufacturers - General
Page snapshot: 17 July 2026, 8:56 pm
View full analysis in the screener → · All most overvalued stocks →
Before you trade on valuation alone
Cross-check fair value with fundamentals, liquidity, and your own goals—this table is a screen, not advice.
Drug Manufacturers - General Industry Valuation Insights (Updated Today)
- The Drug Manufacturers - General industry currently shows an average upside of 40.5% on this snapshot.
- Top name GSK plc (GSK) trades at roughly a 70.6% discount to modeled intrinsic value—rankings move with prices and inputs.
- This industry's average upside is below our broad mostOvervalued benchmark (~95.4%).
MostOvervalued Drug Manufacturers - General Stocks by Market Cap
Large cap (top 5)
- 1.GSK plc · GSK70.6%$105.69B
- 2.Eli Lilly and Company · LLY42.3%$1.1T
- 3.AbbVie Inc. · ABBV38.1%$449.56B
- 4.Gilead Sciences, Inc. · GILD32.5%$169.23B
- 5.Novartis AG · NVS31.9%$291.42B
Mid cap (top 5)
No qualifying names in this bucket on this snapshot.
Small cap (top 5)
No qualifying names in this bucket on this snapshot.
What Are the Most Overvalued Drug Manufacturers - General Stocks?
Most overvalued drug manufacturers - general stocks are names where price sits furthest above modeled fair (intrinsic) value—often expressed as the largest headline downside versus price.
This is not a sell list. Validate each symbol on its company page before you act.
How We Identify the Most Overvalued Drug Manufacturers - General Stocks
We pull an industry-filtered most-overvalued snapshot (price, intrinsic value, downside, cap, sector, country) and rank by headline downside. You can sort and search in the table above.
Rankings can shift intraday as prices and model inputs move. Use the stock screener for custom filters beyond this industry leaderboard.
FAQs
Answers about the most overvalued drug manufacturers - general names, intrinsic value, and how often this list refreshes.
How do you find mostOvervalued drug manufacturers - general stocks?
We load mostOvervalued names for this industry from our API, then rank and filter in the table. Sort columns and open company pages to dig deeper.
Why are drug manufacturers - general stocks mostOvervalued?
Often sentiment, earnings, cycles, rates, or stock-specific news—not always a “misprice.” Intrinsic value is model-dependent.
Are mostOvervalued drug manufacturers - general stocks a good investment?
Not by label alone. Discounts can reflect risk or data lag. Check fundamentals and your goals; seek professional advice if needed.
How often is this list updated?
The page rebuilds on a schedule (ISR). Live quotes can move faster—use company pages for the latest.